Peter Iversen

13.9k total citations
249 papers, 6.0k citations indexed

About

Peter Iversen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Peter Iversen has authored 249 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Pulmonary and Respiratory Medicine, 47 papers in Oncology and 47 papers in Cancer Research. Recurrent topics in Peter Iversen's work include Prostate Cancer Treatment and Research (149 papers), Prostate Cancer Diagnosis and Treatment (119 papers) and Cancer, Lipids, and Metabolism (34 papers). Peter Iversen is often cited by papers focused on Prostate Cancer Treatment and Research (149 papers), Prostate Cancer Diagnosis and Treatment (119 papers) and Cancer, Lipids, and Metabolism (34 papers). Peter Iversen collaborates with scholars based in Denmark, United States and United Kingdom. Peter Iversen's co-authors include Klaus Brasso, Paul O. Madsen, David G. McLeod, Martin Andreas Røder, Reginald C. Bruskewitz, Teuvo L.J. Tammela, Manfred P. Wirth, Kevin Carroll, Ib Jarle Christensen and Klaus Møller‐Ernst Jensen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Peter Iversen

246 papers receiving 5.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter Iversen 4.0k 1.2k 973 851 714 249 6.0k
J. Brantley Thrasher 3.2k 0.8× 640 0.5× 966 1.0× 725 0.9× 1.7k 2.3× 134 6.6k
Nicolas Mottet 6.8k 1.7× 619 0.5× 1.6k 1.6× 991 1.2× 1.5k 2.1× 147 8.6k
Sergio Serni 3.1k 0.8× 878 0.7× 1.5k 1.6× 974 1.1× 1.4k 2.0× 247 7.0k
Patrick C. Walsh 5.0k 1.2× 782 0.6× 563 0.6× 354 0.4× 1.6k 2.3× 109 7.1k
David Gillatt 1.8k 0.5× 381 0.3× 1.1k 1.1× 749 0.9× 1.2k 1.7× 163 5.6k
Mark Garzotto 1.9k 0.5× 302 0.2× 790 0.8× 854 1.0× 411 0.6× 118 3.8k
Charles B. Brendler 3.3k 0.8× 373 0.3× 758 0.8× 414 0.5× 1.6k 2.2× 153 5.7k
Tanya B. Dorff 1.9k 0.5× 307 0.3× 1.6k 1.6× 820 1.0× 879 1.2× 288 5.2k
Joel B. Nelson 6.0k 1.5× 796 0.7× 3.0k 3.0× 1.8k 2.1× 1.4k 1.9× 188 10.8k
Ola Bratt 2.8k 0.7× 249 0.2× 1.1k 1.1× 434 0.5× 581 0.8× 156 4.0k

Countries citing papers authored by Peter Iversen

Since Specialization
Citations

This map shows the geographic impact of Peter Iversen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Iversen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Iversen more than expected).

Fields of papers citing papers by Peter Iversen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Iversen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Iversen. The network helps show where Peter Iversen may publish in the future.

Co-authorship network of co-authors of Peter Iversen

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Iversen. A scholar is included among the top collaborators of Peter Iversen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Iversen. Peter Iversen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ebbehøj, Andreas, Peter Iversen, Stine Kramer, et al.. (2024). Positron Emission Tomography Imaging of Pheochromocytoma and Paraganglioma—18F-FDOPA vs Somatostatin Analogues. The Journal of Clinical Endocrinology & Metabolism. 110(2). 303–316. 2 indexed citations
2.
Iversen, Peter, Stine Kramer, Andreas Ebbehøj, et al.. (2023). [18F]FDOPA PET/CT is superior to [68Ga]DOTATOC PET/CT in diagnostic imaging of pheochromocytoma. EJNMMI Research. 13(1). 18–22. 7 indexed citations
3.
Larsen, Signe Benzon, et al.. (2020). What is the risk of prostate cancer mortality following negative systematic TRUS-guided biopsies? A systematic review. BMJ Open. 10(12). e040965–e040965. 5 indexed citations
4.
Bryce, Alan H., Joshi J. Alumkal, Andrew J. Armstrong, et al.. (2017). Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL. Prostate Cancer and Prostatic Diseases. 20(2). 221–227. 71 indexed citations
5.
Nielsen, Roni, Anders Jorsal, Peter Iversen, et al.. (2017). Effect of liraglutide on myocardial glucose uptake and blood flow in stable chronic heart failure patients: A double-blind, randomized, placebo-controlled LIVE sub-study. Journal of Nuclear Cardiology. 26(2). 585–597. 34 indexed citations
6.
Chowdhury, S., Neal D. Shore, Fred Saad, et al.. (2016). Fatigue in men with metastatic castration-resistant prostate cancer treated with enzalutamide: data from randomised clinical trials. Annals of Oncology. 27. vi250–vi250. 2 indexed citations
7.
Helgstrand, John Thomas, Klaus Brasso, Ben Vainer, et al.. (2016). Risk of prostate cancer mortality in men with an initial benign needle core biopsy set: a population based analysis with up to 20 years of follow-up. Annals of Oncology. 27. vi246–vi246. 1 indexed citations
8.
Larsen, Signe Benzon, Klaus Brasso, Jane Christensen, et al.. (2016). Socioeconomic position and mortality among patients with prostate cancer: influence of mediating factors. Annals of Oncology. 27. vi476–vi476. 4 indexed citations
9.
Berg, Kasper Drimer, Klaus Brasso, Frederik Birkebæk Thomsen, et al.. (2015). ERG protein expression over time: from diagnostic biopsies to radical prostatectomy specimens in clinically localised prostate cancer. Journal of Clinical Pathology. 68(10). 788–794. 9 indexed citations
10.
Iversen, Peter, Kim Mouridsen, Mikkel Bo Hansen, et al.. (2014). Oxidative metabolism of astrocytes is not reduced in hepatic encephalopathy: a PET study with [11C]acetate in humans. Frontiers in Neuroscience. 8. 353–353. 17 indexed citations
11.
Thomsen, Frederik Birkebæk, Klaus Brasso, Laurence Klotz, et al.. (2014). Active surveillance for clinically localized prostate cancer––A systematic review. Journal of Surgical Oncology. 109(8). 830–835. 122 indexed citations
12.
Røder, Martin Andreas, et al.. (2013). Patients undergoing radical prostatectomy have a better survival than the background population.. PubMed. 60(4). A4612–A4612. 5 indexed citations
13.
Larsen, Signe Benzon, Klaus Brasso, Peter Iversen, et al.. (2013). Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort. European Journal of Cancer. 49(14). 3041–3048. 8 indexed citations
14.
Iversen, Peter, et al.. (2012). PRM21 Medline and Embase for Health Economic Literature Reviews. Value in Health. 15(4). A162–A162. 2 indexed citations
15.
Borre, Michael & Peter Iversen. (2007). Screening for prostatacancer--hvad siger evidensen?. Ugeskrift for Læger. 169(20). 1 indexed citations
16.
Johansen, Julia S., Klaus Brasso, Peter Iversen, et al.. (2007). Changes of Biochemical Markers of Bone Turnover and YKL-40 Following Hormonal Treatment for Metastatic Prostate Cancer Are Related to Survival. Clinical Cancer Research. 13(11). 3244–3249. 46 indexed citations
17.
Tombal, Bertrand, Peter Iversen, Hendrik Van Poppel, et al.. (2006). Determining the dose of degarelix for effective therapy of prostate cancer patients as investigated by the degarelix study groups. Annals of Oncology. 17. 150–150. 2 indexed citations
18.
Brasso, Klaus, S. Friis, Knud Juel, Torben Jørgensen, & Peter Iversen. (1999). Morbidity in patients with clinically localized prostate cancer managed with non-curative intent. A population-based case–control study. Prostate Cancer and Prostatic Diseases. 2(5-6). 253–256. 2 indexed citations
19.
Iversen, Peter, Stefan Suciu, Richard Sylvester, Ib Jarle Christensen, & L. Denis. (1990). Zoladex and Flutamide Versus Orchiectomy in the Treatment of Advanced Prostatic Cancer. Cancer. 66(S5). 1067–1073. 25 indexed citations
20.
Iversen, Peter & Paul O. Madsen. (1982). Bacterial adherence to urothelium following bladder irrigation in the rat. Infection. 10(2). 116–119. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Brantley Thrasher Breakdown of academic impact, for papers by Nicolas Mottet Breakdown of academic impact, for papers by Sergio Serni Breakdown of academic impact, for papers by Patrick C. Walsh Breakdown of academic impact, for papers by David Gillatt Breakdown of academic impact, for papers by Mark Garzotto Breakdown of academic impact, for papers by Charles B. Brendler Breakdown of academic impact, for papers by Tanya B. Dorff Breakdown of academic impact, for papers by Joel B. Nelson Breakdown of academic impact, for papers by Ola Bratt
Rankless by CCL
2026